Develop strategies for achieving distinction in targeted areas of translational research that link scientific discovery to high priority clinical programs (Mid-Point Progress Report).

  • R2a. Target Areas of Priority:
    • Develop new departments and programs of national distinction in targeted areas of translational research linked to areas of clinical priority such as interdisciplinary oncology, translational neurosciences and cardiovascular biology.
      • Lead: Guy Reed, MD, MS.